Literature DB >> 16359490

Understanding heart development and congenital heart defects through developmental biology: a segmental approach.

Masahide Sakabe1, Hiroko Matsui, Hirokazu Sakata, Katsumi Ando, Toshiyuki Yamagishi, Yuji Nakajima.   

Abstract

ABSTRACT The heart is the first organ to form and function during development. In the pregastrula chick embryo, cells contributing to the heart are found in the postero-lateral epiblast. During the pregastrula stages, interaction between the posterior epiblast and hypoblast is required for the anterior lateral plate mesoderm (ALM) to form, from which the heart will later develop. This tissue interaction is replaced by an Activin-like signal in culture. During gastrulation, the ALM is committed to the heart lineage by endoderm-secreted BMP and subsequently differentiates into cardiomyocyte. The right and left precardiac mesoderms migrate toward the ventral midline to form the beating primitive heart tube. Then, the heart tube generates a right-side bend, and the d-loop and presumptive heart segments begin to appear segmentally: outflow tract (OT), right ventricle, left ventricle, atrioventricular (AV) canal, atrium and sinus venosus. T-box transcription factors are involved in the formation of the heart segments: Tbx5 identifies the left ventricle and Tbx20 the right ventricle. After the formation of the heart segments, endothelial cells in the OT and AV regions transform into mesenchyme and generate valvuloseptal endocardial cushion tissue. This phenomenon is called endocardial EMT (epithelial-mesenchymal transformation) and is regulated mainly by BMP and TGFbeta. Finally, heart septa that have developed in the OT, ventricle, AV canal and atrium come into alignment and fuse, resulting in the completion of the four-chambered heart. Altered development seen in the cardiogenetic process is involved in the pathogenesis of congenital heart defects. Therefore, understanding the molecular nature regulating the 'nodal point' during heart development is important in order to understand the etiology of congenital heart defects, as well as normal heart development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359490     DOI: 10.1111/j.1741-4520.2005.00079.x

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  7 in total

Review 1.  A gene regulatory program controlling early Xenopus mesendoderm formation: Network conservation and motifs.

Authors:  Rebekah M Charney; Kitt D Paraiso; Ira L Blitz; Ken W Y Cho
Journal:  Semin Cell Dev Biol       Date:  2017-03-22       Impact factor: 7.727

Review 2.  Heart regeneration: 20 years of progress and renewed optimism.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Dev Cell       Date:  2022-02-28       Impact factor: 12.270

Review 3.  A bHLH code for cardiac morphogenesis.

Authors:  Simon J Conway; Beth Firulli; Anthony B Firulli
Journal:  Pediatr Cardiol       Date:  2009-12-24       Impact factor: 1.655

4.  Epithelial Mesenchymal Transition: a double-edged sword.

Authors:  Guislaine Barriere; Pietro Fici; Giulia Gallerani; Francesco Fabbri; Michel Rigaud
Journal:  Clin Transl Med       Date:  2015-04-14

5.  Embryonic Development of Heart in Indian Buffalo (Bubalus bubalis).

Authors:  Anuradha Gupta; Neelam Bansal; Varinder Uppal
Journal:  Int Sch Res Notices       Date:  2014-09-30

6.  Ascorbic acid promotes cardiomyogenesis through SMAD1 signaling in differentiating mouse embryonic stem cells.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Daniel R Riordon; Yelena Tarasova; Kenneth R Boheler
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

7.  Uncovering the rare variants of DLC1 isoform 1 and their functional effects in a Chinese sporadic congenital heart disease cohort.

Authors:  Bin Lin; Yufeng Wang; Zhen Wang; Huilian Tan; Xianghua Kong; Yang Shu; Yuchao Zhang; Yun Huang; Yufei Zhu; Heng Xu; Zhiqiang Wang; Ping Wang; Guang Ning; Xiangyin Kong; Guohong Hu; Landian Hu
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.